Article

CMS site answers accommodative IOL FAQs

Washington, DC-Ophthalmologists whose patients choose a presbyopia-correcting IOL following cataract surgery do not need to have the Medicare beneficiary sign a waiver or advanced beneficiary notice (ABN) prior to surgery.

Washington, DC-Ophthalmologists whose patients choose a presbyopia-correcting IOL following cataract surgery do not need to have the Medicare beneficiary sign a waiver or advanced beneficiary notice (ABN) prior to surgery.

The explanation was posted on the Centers for Medicare and Medicaid Services (CMS) Web site, along with answers to other frequently asked questions about Medicare and these IOLs.

The answers were compiled by the American Society of Cataract and Refractive Surgery (ASCRS) and CMS after many ophthalmologists requested clarification on the policy.

According to the explanations offered, a beneficiary does not need a waiver or ABN because there is no decision made as to whether the IOL is medically "reasonable and necessary." However, a practice might choose to offer a Notice of Exclusion of Medicare Benefit (NEMB) to clarify that the patient-and not Medicare- is responsible for additional costs associated with the presbyopia-correcting IOL. The NEMB is available on the CMS Web site at http://cms.hhs.gov/medicare/bni/20007_English.pdf.

The FAQ answer also explains that each medical facility may determine the amount it charges patients for implanting the accommodative IOL, because Medicare will not determine "standard and customary" charges for a non-covered service.

"The ASC may charge the beneficiary for any additional costs associated with insertion of the presbyopia-correcting IOL," the answer states.

In addition, CMS clarifies that it will pay for one pair of eyeglasses or contact lenses following cataract surgery, even if the beneficiary chooses an accommodative IOL.

More information is available from the Web site at http:// http://tinyurl.com/nrtru/.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.